TITLE

Denying science

PUB. DATE
April 2006
SOURCE
Nature Medicine;Apr2006, Vol. 12 Issue 4, p369
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article comments on the movement of AIDS denialists in spreading conspiracy theories and misinformation to a susceptible public wary of antiretroviral drugs. Scientists have a very important role to play in explaining the science behind AIDS and showing that antiretroviral drugs can effectively treat the disease.
ACCESSION #
20393552

 

Related Articles

  • HIV service delivery models towards 'Zero AIDS-related Deaths': a collaborative case study of 6 Asia and Pacific countries. Fujita, Masami; Poudel, Krishna C.; Green, Kimberly; Wi, Teodora; Abeyewickreme, Iyanthi; Ghidinelli, Massimo; Kato, Masaya; Mean Chhi Vun; Sopheap, Seng; Khin Ohnmar San; Bollen, Phavady; Rai, Krishna Kumar; Dahal, Atul; Bhandari, Durga; Boas, Peniel; Yaipupu, Jessica; Sirinirund, Petchsri; Saonuam, Pairoj; Bui Duc Duong; Do Thi Nhan // BMC Health Services Research;2015, Vol. 15 Issue 1, p1 

    Background: In the Asia-Pacific region, limited systematic assessment has been conducted on HIV service delivery models. Applying an analytical framework of the continuum of prevention and care, this study aimed to assess HIV service deliveries in six Asia and Pacific countries from the...

  • Tenofovir and Nephrotoxicity. Joshi, Amit; Kraus, Mark // Kidney;Nov/Dec2005, Vol. 14 Issue 6, p255 

    The article provides information on the development of antiretroviral drug tenofovir for the treatment of HIV/AIDS. Tenofovir is an acyclic nucleoside phosphonate in the class of nucleotide reverse transcriptase inhibitors. The drug interrupts DNA synthesis by terminating the elongation of the...

  • HIV/AIDS: Recent Advances in Antiretroviral Agents. Nikolopoulos, Georgios; Bonovas, Stefanos; Tsantes, Argirios; Sitaras, Nikolaos M. // Mini Reviews in Medicinal Chemistry;Jul2009, Vol. 9 Issue 8, p900 

    Despite the considerable progress in antiretroviral therapy, the eradication of HIV-1 remains unfeasible. Therefore, novel agents are under investigation. The aim of this review is to summarize the conventional compounds, to describe the recently approved agents, and to take a comprehensive look...

  • Antiretroviral Therapy and Sexual Behavior: A Comparative Study between Antiretroviral- Naive and -Experienced Patients at an Urban HIV/AIDS Care and Research Center in Kampala, Uganda. Bateganya, Moses; Colfax, Grant; Shafer, Leigh Anne; Kityo, Cissy; Mugyenyi, Peter; Serwadda, David; Mayanja, Harriet; Bangsberg, David // AIDS Patient Care & STDs;Nov2005, Vol. 19 Issue 11, p760 

    We examined whether use of antiretroviral (ARV) therapy is associated with increased sexual risk behavior in a cross-sectional study of patients undergoing ARV therapy (ARV experienced) compared to patients not undergoing ARV therapy (ARV-naïve) attending an urban HIV clinic in Kampala,...

  • HIV and Hyperlipidemia: Current Recommendations And Treatment. Capili, Bernadette; Anastasi, Joyce K. // MEDSURG Nursing;Feb2006, Vol. 15 Issue 1, p14 

    The article discusses the Highly Active Antiretroviral Therapies (HAART) as a big factor in fighting HIV and AIDS. Cardiovascular disease is also recognized as one of the subsequent diseases which is a result from AIDS virus. It was found out that this life threatening condition has now become...

  • Randomized, Controlled Trial of Therapy Interruption in Chronic HIV-1 Infection. Papasavvas, Emmanouil; Kostman, Jary R.; Mounzer, Karam; Grant, Robert M.; Gross, Robert; Gallo, Cele; Azzoni, Livio; Foulkes, Andrea; Thiel, Brian; Pistilli, Maxwell; Mackiewicz, Agnieszka; Shull, Jane; Montaner, Luis J. // PLoS Medicine;Dec2004, Vol. 1 Issue 3, p218 

    Background Approaches to limiting exposure to antiretroviral therapy (ART) drugs are an active area of HIV therapy research. Here we present longitudinal follow-up of a randomized, open-label, single-center study of the immune, viral, and safety outcomes of structured therapy interruptions (TIs)...

  • Uptake of HIV testing and treatment in an isolated population with access to free and universal healthcare. Gillieatt, Sue J.; Mallal, Simon A.; Gillieatt, S J; Mallal, S A // International Journal of STD & AIDS;May2000, Vol. 11 Issue 5, p303 

    This Western Australian study analysed clinical information from 344 people with AIDS, and experiential data from a sample of 36 people with AIDS to investigate 2 relevant issues: the timing of HIV testing and uptake and experiences of HIV drug treatment. We found that the proportion of people...

  • Antiretroviral therapy in the developing world. Chulamokha, Lalita; DeSimone, Joseph A.; Pomerantz, Roger J. // Journal of NeuroVirology;Apr2005 Supplment 1, Vol. 11, p76 

    Discusses the benefits of antiretroviral therapy in HIV infection and AIDS. Reduction in the transmission and spread of HIV; Underlying mechanism of the treatment's action; Means in the prevention of vertical transmission.

  • AIDS In Africa: Puzzling, Harrowing Pictures. Cohen, Marcus A. // Townsend Letter for Doctors & Patients;Nov2005, Issue 268, p32 

    Comments on various issues associated with the increasing rate of AIDS cases in Africa. List of opportunistic diseases for diagnosis during the early AIDS period; Discouragement on published studies that support the medical orthodoxy on HIV and antiretroviral drug therapy; Doubt about the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics